![PharmaTalkRadio artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/a8/76/ea/a876eaec-f9ae-a355-f856-8dd8b8dc62f1/mza_8144839391309294325.jpg/100x100bb.jpg)
Merck’s Digital Health and Al Strategy: Progress Report
PharmaTalkRadio
English - August 07, 2019 14:00 - 15 minutes - 13.2 MB - ★★★★ - 16 ratingsScience pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: How Digital Biomarker Innovation is Modernizing Clinical Endpoints
In this session presented at the Mobile in Clinical Trials 2018 conference, Merck's Kai Bode and Jyoti Shah share an exciting update on the company's progress in implementing a digital health and AI strategy. Session takeaways include:
What Merck is doing in digital health and AIExternal collaborations on AISmart trial initiative to enable patient-centric studies
Kai Bode is returning to Mobile 2019 to share an update on Merck's digital strategy 2.0 and how they are engineering for scale.
Speakers: Jyoti Shah, Associate Director, Data Development MRL IT, Merck & Co, Inc
Kai Bode, Director, Digital and Analytics Technology, Merck & Co, Inc